All In MedTech

Device Trial Radar · NCT03762408

Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.

Comparative Study of the Efficacy and Safety of an Intra-articular Injection of ENKO 1 vs Durolane in Patients With Symptomatic Osteoarthritis of the Knee.

Last checked: Nov 20, 2026Latest source record: Mar 23, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 175 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

175

Actual

Start

Dec 15, 2017

Primary completion

May 29, 2020

Study completion May 29, 2020

Sponsor

Lead sponsor
OPKO Health, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Osteoarthritis Foundation International (OAFI)
First posted
Dec 3, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Clinical trial with medical device, multicenter, single-blind (blind third party evaluation), randomized, comparative and in two paralell groups, to demonstrate the treatment according to usual clinical practice, of the combination of 50 mg Sodium Hyaluronate and 50 mg Chondroitin Sulfate (ENKO 1) in a single administration, has non-inferiority efficacy vs the comparator (Durolane; 60 mg HA crosslinked) in patients with symptomatic knee osteoarthritis after three months of follow-up.

Conditions

  • Osteoarthritis, Knee

Interventions

  • ENKO 1Device

    50 mg of HA/ 50 mg of CS in 5 ml

  • DurolaneDevice

    60 mg HA crosslinked in 3 ml

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain ReliefTime frame: Change from baseline pain relief at 6 months.

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Instituto Médico Arriaza

    A Coruña, Spain

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.